MarketPeel
Insider Trading Intelligence
Pricing
…
JO

Jacob A. Orville

ABT
SENIOR VICE PRESIDENT · ABBOTT LABORATORIES · CIK 0001263312
FILING MIX · LIFETIME40%/60%
BUYS
42
SELLS
63
TOTAL VALUE
$11.29M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
50,493
AVG SELL PX
$86.33
TRADE KIND
SHOWING 105 / 105
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Jacob A. Orville, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+58.82%-1.48%-0.64%-0.84%-0.70%—
14d17+58.82%-3.09%-1.00%-2.08%-0.93%—
30d17+58.82%-1.82%+0.42%-2.24%-3.20%—
60d17+58.82%-2.82%+1.09%-3.92%-2.57%—
90d17+58.82%-5.34%+0.98%-6.33%-18.55%—
180d17+56.25%-8.39%+7.21%-15.30%-14.69%—
1y17(1 pending)+93.75%-14.23%+16.34%-30.57%-37.43%—
2y17(1 pending)+75.00%-2.57%+36.01%-38.58%-53.19%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 42 buys / 63 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
153,726——0Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
1,774——0Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
53,323——153,726Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
38,707——0Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
6,581——0Mar 23, 2026Mar 23, 2026 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
13,255——50,493Mar 23, 2026Mar 25, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
38,707——38,707Feb 25, 2026Feb 27, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
4,426$101.82$450.7K100,403Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
13,527$101.82$1.38M53,460Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
9,675$101.82$985.1K95,413Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
4,442$101.82$452.3K30,341Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
9,416——104,829Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
16,051——69,511Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
6,978$101.82$710.5K38,208Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
19,986$101.82$2.03M84,504Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
7,544$101.82$768.1K61,967Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
3,955——27,192Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
9,450——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
3,955——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
42,523——104,490Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
28,779——66,987Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
9,450——34,783Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
16,051——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
14,845——45,186Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
14,845——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
20,584——105,088Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
1,859$101.82$189.3K25,333Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
28,779——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
5,000$75.00$375.0K23,237Nov 19, 2025Nov 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
2,515$46.83$117.8K28,237Aug 5, 2025Aug 7, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
5,350——16,051Aug 5, 2025Aug 7, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
5,350——30,752Aug 5, 2025Aug 7, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
2,221$47.82$106.2K22,780Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
2,326$47.82$111.2K25,402Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
4,948——14,845Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
4,948——27,728Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
4,725——25,001Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
4,725——9,450Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
3,954——3,955Feb 25, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
1,859$51.28$95.3K20,277Feb 25, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
3,954——22,136Feb 25, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
28,779——28,779Feb 24, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
2,225$50.48$112.3K18,182Feb 20, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
4,805——20,407Feb 20, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
1,086$49.63$53.9K15,602Feb 19, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Screening
2,248——0Feb 19, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Screening
2,248——16,688Feb 19, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
21,401——21,401Aug 5, 2024Aug 6, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
102$60.15$6.1K14,440May 1, 2024May 2, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
218——14,542Apr 30, 2024May 2, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
2,154$59.32$127.8K14,324Mar 1, 2024Mar 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
4,724——16,478Feb 29, 2024Mar 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
4,724——14,175Feb 29, 2024Mar 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,879$56.89$106.9K11,754Feb 27, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
3,954——7,909Feb 26, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
3,954——13,633Feb 26, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
19,793——19,793Feb 26, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,013$59.78$60.6K9,679Feb 22, 2024Feb 23, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,078$61.50$66.3K8,658Feb 21, 2024Feb 22, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
2,034——10,692Feb 21, 2024Feb 23, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
2,248——0Feb 20, 2024Feb 22, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
2,248——9,736Feb 20, 2024Feb 22, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
966$61.43$59.3K7,488Feb 15, 2024Feb 16, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
2,031——8,454Feb 14, 2024Feb 16, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
2,031——0Feb 14, 2024Feb 16, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
5,000$80.00$400.0K6,423May 10, 2023May 12, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
5,000$65.00$325.0K11,423Mar 3, 2023Mar 7, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
5,000$59.98$299.9K18,255Feb 28, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
1,832$61.12$112.0K16,423Feb 28, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
3,954——11,863Feb 27, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
3,954——23,255Feb 27, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
18,899——18,899Feb 24, 2023Feb 28, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
2,710$62.72$170.0K19,301Feb 22, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
2,248——4,495Feb 21, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
2,248——22,011Feb 21, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
3,649——0Feb 21, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
3,649——19,763Feb 21, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
954$69.59$66.4K16,114Feb 15, 2023Feb 16, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, Screening
2,030——17,068Feb 14, 2023Feb 16, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, Screening
2,030——2,031Feb 14, 2023Feb 16, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
15,817——15,817Feb 25, 2022Mar 1, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
4,717$70.10$330.7K15,037Feb 24, 2022Feb 25, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
1,125$69.05$77.7K9,557Feb 23, 2022Feb 24, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
10,197——19,754Feb 23, 2022Feb 25, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
10,197——0Feb 23, 2022Feb 25, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
2,247——10,682Feb 22, 2022Feb 24, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
2,247——6,744Feb 22, 2022Feb 24, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
1,749$72.72$127.2K8,435Feb 22, 2022Feb 23, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
3,649——3,648Feb 18, 2022Feb 23, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
3,649$74.13$270.5K10,184Feb 18, 2022Feb 23, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
940$79.55$74.8K6,535Feb 15, 2022Feb 16, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
2,030$78.33$159.0K7,475Feb 14, 2022Feb 16, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
2,030——4,061Feb 14, 2022Feb 16, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
8,991——8,991Feb 19, 2021Feb 23, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
1,696$143.38$243.2K5,445Feb 19, 2021Feb 22, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
3,649——7,298Feb 18, 2021Feb 22, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
3,649——7,141Feb 18, 2021Feb 22, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
1,033$142.66$147.4K3,492Feb 17, 2021Feb 18, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
2,030——6,091Feb 16, 2021Feb 18, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
2,030——4,525Feb 16, 2021Feb 18, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
1,153$100.68$116.1K2,495Feb 19, 2020Feb 20, 2020 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Manager, New Ventures
3,648——3,648Feb 18, 2020Feb 20, 2020 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
General Manager, New Ventures
3,648——10,946Feb 18, 2020Feb 20, 2020 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
6,581——6,581Feb 14, 2020Feb 18, 2020 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
8,121——8,121Feb 14, 2020Feb 18, 2020 ↗View →
Other insiders · ABT
Loading peer insiders…
About this filer
CIK 0001263312
ROLE
Senior Vice President
PRIMARY
ABT
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001263312DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback